ATE481983T1 - Frpb proteinmutante und verfahren zur erneuten faltung - Google Patents

Frpb proteinmutante und verfahren zur erneuten faltung

Info

Publication number: ATE481983T1
Authority: AT; Austria
Prior art keywords: frpb protein; protein mutant; refolding method; frpb; refolding
Prior art date: 2002-08-30

Application number

AT03779785T

Other languages

English (en)

Inventor

Ralph Biemans

Philippe Denoel

Christiane Feron

Carine Goraj

Jeroen Kortekaas

Jan Poolman

Jan Tommassen

Vincent Weynants

Original Assignee

Glaxosmithkline Biolog Sa

Univ Utrecht

Technology Foundation Stichtin

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-30

Filing date

2003-08-28

Publication date

2010-10-15

2003-08-28 Application filed by Glaxosmithkline Biolog Sa, Univ Utrecht, Technology Foundation Stichtin filed Critical Glaxosmithkline Biolog Sa

2010-10-15 Application granted granted Critical

2010-10-15 Publication of ATE481983T1 publication Critical patent/ATE481983T1/de

Links

102000004169 proteins and genes Human genes 0.000 title abstract 4
108090000623 proteins and genes Proteins 0.000 title abstract 4
238000000034 method Methods 0.000 title abstract 2
150000001413 amino acids Chemical class 0.000 abstract 1
238000012217 deletion Methods 0.000 abstract 1
230000037430 deletion Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
- A61K39/1045—Moraxella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Mycology (AREA)
Microbiology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Treatment Of Liquids With Adsorbents In General (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT03779785T 2002-08-30 2003-08-28 Frpb proteinmutante und verfahren zur erneuten faltung ATE481983T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0220199.4A GB0220199D0 (en)	2002-08-30	2002-08-30	Mutant protein and refolding method
PCT/EP2003/009634 WO2004020463A2 (en)	2002-08-30	2003-08-28	Mutant protein and refolding method

Publications (1)

Publication Number	Publication Date
ATE481983T1 true ATE481983T1 (de)	2010-10-15

Family

ID=9943242

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03779785T ATE481983T1 (de)	2002-08-30	2003-08-28	Frpb proteinmutante und verfahren zur erneuten faltung

Country Status (10)

Country	Link
US (1)	US20060141563A1 (de)
EP (1)	EP1572729B1 (de)
JP (1)	JP2006516183A (de)
AT (1)	ATE481983T1 (de)
AU (1)	AU2003287945A1 (de)
CA (1)	CA2495086A1 (de)
DE (1)	DE60334316D1 (de)
ES (1)	ES2351598T3 (de)
GB (1)	GB0220199D0 (de)
WO (1)	WO2004020463A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2414667A (en)	2004-06-03	2005-12-07	Isis Innovation	Vaccine compositions of N. meningitidis PorA and FetA antigens
US9486515B2 (en)	2005-06-27	2016-11-08	Glaxosmithkline Biologicals S.A.	Immunogenic composition
EP2032161B1 (de) *	2006-06-12	2012-07-11	GlaxoSmithKline Biologicals S.A.	L3v los impfstoffe
WO2010074126A1 (ja) *	2008-12-25	2010-07-01	財団法人化学及血清療法研究所	組換え鶏伝染性コリーザワクチン及びその製造方法
ES2759484T3 (es) *	2010-09-10	2020-05-11	Glaxosmithkline Biologicals Sa	Meningococo que sobreexpresa NadA y/o NHBA y vesículas de la membrana externa derivadas del mismo
WO2012041899A1 (en) *	2010-09-28	2012-04-05	Xbrane Bioscience Ab	Fusion protein for secretory protein expression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6265567B1 (en) *	1995-04-07	2001-07-24	University Of North Carolina At Chapel Hill	Isolated FrpB nucleic acid molecule
EP0943690B1 (de) *	1995-12-21	2006-11-29	Ajinomoto Co., Inc.	Verfahren zur rückfaltung von menschlichem activin a
EP1252182B1 (de) *	2000-01-25	2012-06-20	The University Of Queensland	KONSERVIERTE REGIONEN DES NEISSERIA MENINGITIDIS OBERFLÄCHENANTIGENS NhhA ENTHALTENDE PROTEINE

2002
- 2002-08-30 GB GBGB0220199.4A patent/GB0220199D0/en not_active Ceased
2003
- 2003-08-28 AT AT03779785T patent/ATE481983T1/de not_active IP Right Cessation
- 2003-08-28 DE DE60334316T patent/DE60334316D1/de not_active Expired - Lifetime
- 2003-08-28 CA CA002495086A patent/CA2495086A1/en not_active Abandoned
- 2003-08-28 ES ES03779785T patent/ES2351598T3/es not_active Expired - Lifetime
- 2003-08-28 AU AU2003287945A patent/AU2003287945A1/en not_active Abandoned
- 2003-08-28 EP EP03779785A patent/EP1572729B1/de not_active Expired - Lifetime
- 2003-08-28 JP JP2004532151A patent/JP2006516183A/ja active Pending
- 2003-08-28 WO PCT/EP2003/009634 patent/WO2004020463A2/en not_active Ceased
- 2003-08-28 US US10/526,062 patent/US20060141563A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2006516183A (ja)	2006-06-29
EP1572729A2 (de)	2005-09-14
EP1572729B1 (de)	2010-09-22
AU2003287945A8 (en)	2004-03-19
GB0220199D0 (en)	2002-10-09
ES2351598T3 (es)	2011-02-08
AU2003287945A1 (en)	2004-03-19
US20060141563A1 (en)	2006-06-29
WO2004020463A3 (en)	2005-08-18
WO2004020463A2 (en)	2004-03-11
CA2495086A1 (en)	2004-03-11
DE60334316D1 (de)	2010-11-04

Similar Documents

Publication	Publication Date	Title
BRPI0418286A (pt)	2007-05-02	proteìnas de fusão de il-7
ATE450619T1 (de)	2009-12-15	Defructosylierungsverfahren
EP2444809A3 (de)	2013-07-24	Verfahren zur Herstellung und zum Screening von Proteasen mit veränderter Spezifizität
DE60335733D1 (de)	2011-02-24	Verfahren zur solubilisierung von protein
EP1623227A4 (de)	2009-03-04	Proteine, sensoren und verfahren zur charakterisierung von analyten damit
DK1668001T3 (da)	2009-02-16	Substituerede heteroarylbenzofuransyrer
DK1530637T3 (da)	2010-05-31	Carlsberg-subtilisin-proteiner med nedsat immunogenitet
EP1482858A4 (de)	2007-05-30	Verfahren für die reparation von aneurysmen
ATE484201T1 (de)	2010-10-15	Verwendung von beta-cryptoxanthin
DE69933551D1 (de)	2006-11-23	Menschliche protease und verwendung davon für pharmazeutischen anwendungen und zur reduktion der allergisierenden wirkung von nicht-menschlichen proteinen
ATE492631T1 (de)	2011-01-15	Verwendung von mutationen zur verbesserung von aspergillus-phytasen
ATE481983T1 (de)	2010-10-15	Frpb proteinmutante und verfahren zur erneuten faltung
DE60118935D1 (de)	2006-05-24	Dna & protein bindende miniatur proteine
ATE495243T1 (de)	2011-01-15	Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung
DE60325194D1 (de)	2009-01-22	Methoden zur verwendung von lamellaren körpern für therapeutische zwecke
TW200700089A (en)	2007-01-01	Recombinant protein comprising starch binding domain and use thereof
DE50308032D1 (de)	2007-10-04	Isoliertes fluoreszierendes protein aus clytia gregaria cgfp, sowie dessen verwendung
DE50309626D1 (de)	2008-05-29	Verfahren zur vorhersage der expressionseffizienz in zellfreien expressionssystemen
DE60326446D1 (de)	2010-04-01	Zusammensetzungen auf basis von kieselsäure und protein-autolysate zur anlockung und bekämpfung von arthropoden
ATE269905T1 (de)	2004-07-15	Verfahren zur herstellung von proteinen in wirtszellen unter verwendung von chaperoninen
DE60215206D1 (de)	2006-11-16	Enzymatisches verfahren zur enantiomeren trennung von aminosäuren
ATE451457T1 (de)	2009-12-15	Verfahren zur dipeptidherstellung
ATE437650T1 (de)	2009-08-15	Tyrosinasemutante und verfahren zur verwendung davon
DE60317620D1 (de)	2008-01-03	Methode zur Bestimmung von UDP-GlcNac
BRPI0408023A (pt)	2006-02-14	métodos para previnir gliconoilação de proteìnas

Legal Events

Date	Code	Title	Description
2011-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties